跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
在 國立陽明交通大學研發優勢分析平台 搜尋內容
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
查看斯高帕斯 (Scopus) 概要
胡瑜峰 Yu-Feng
教授
生物藥學研究所
h-index
h10-index
h5-index
10702
引文
55
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
3646
引文
33
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
710
引文
13
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2005
2026
每年研究成果
概覽
指紋
網路
研究成果
(363)
類似的個人檔案
(7)
指紋
查看啟用 Yu-Feng Hu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Atrial Fibrillation
98%
Catheter Ablation
69%
Ablation
30%
Paroxysmal Atrial Fibrillation
29%
Atrial Fibrillation Ablation
28%
Ventricular Arrhythmia
27%
Pulmonary Vein Isolation
25%
Atrial Substrate
19%
Atrial Fibrillation Recurrence
16%
Persistent Atrial Fibrillation
15%
CHA2DS2-VASc Score
14%
Electrophysiological Characteristics
12%
Pulmonary Vein
11%
Non-paroxysmal Atrial Fibrillation
11%
Sinus Rhythm
11%
Left Atrium
11%
Left Atrial
11%
Confidence Interval
11%
National Cohort Study
10%
Arrhythmogenic Right Ventricular Cardiomyopathy
10%
Hazard Ratio
9%
Substrate Properties
9%
Ventricular Tachycardia
9%
Electrogram
9%
Ablation Outcomes
9%
Arrhythmogenic Right Ventricular Dysplasia
8%
Radiofrequency Catheter Ablation
8%
Taiwan
8%
Ischemic Stroke
7%
Atrial Arrhythmia
7%
Oral Anticoagulants
7%
Sudden Cardiac Death
7%
Right Ventricular Outflow Tract
6%
Clinical Characteristics
6%
Atrium
6%
Left Atrial Diameter
6%
Risk of Ischemic Stroke
6%
Clinical Outcomes
6%
Atrial Tachycardia
6%
Drug Refractory
6%
Complex Fractionated Atrial Electrograms
6%
Warfarin
5%
Asian Patients
5%
Ablation Therapy
5%
Endocardium
5%
Arrhythmia Management
5%
Stroke Risk
5%
New-onset Atrial Fibrillation
5%
Substrate Characteristics
5%
Scar
5%
Medicine and Dentistry
Atrial Fibrillation
100%
Ablation
70%
Recurrent Disease
32%
Paroxysmal Atrial Fibrillation
28%
Pulmonary Vein Isolation
24%
Heart Ventricle Arrhythmia
20%
Ventricular Tachycardia
19%
Pulmonary Vein
16%
Arrhythmogenic Right Ventricular Dysplasia
15%
Electrography
14%
Apoplexy
13%
Left Atrium
12%
CHA2DS2-VASc Score
11%
Persistent Atrial Fibrillation
11%
Cardiac Dysrhythmia
10%
Antithrombotic
10%
Atrial Fibrillation Ablation
9%
Sinus Rhythm
9%
Cohort Analysis
9%
Ventricular Outflow Tract
8%
Supraventricular Tachycardia
8%
Electrocardiogram
8%
Congestive Heart Failure
8%
Myocardial Disease
8%
Hazard Ratio
8%
Ablation Therapy
7%
Brain Ischemia
7%
Atrial Flutter
7%
Sudden Cardiac Death
7%
Cardiovascular System
6%
Atrial Electrogram
6%
Risk Stratification
6%
Atrium
6%
Premature Ventricular Contraction
6%
Endocardium
6%
Heart Rhythm
5%
